The Medicines and Healthcare products Regulatory Agency (MHRA) has approved depemokimab (Exdensur, GSK plc) as add-on therapy for severe asthma and for chronic rhinosinusitis with nasal polyps (CRSwNP ...

A monthly injection could help people with severe asthma come off daily steroid tablets entirely without any impact on symptoms, a trial has found. Tezepelumab – also known as Tezspire and made by ...

Monthly Injection Could Free People With Severe Asthma From Steroids By Ernie Mundell HealthDay ReporterMONDAY, Dec. 1, 2025 (HealthDay News) — People with severe asthma often take daily steroid ...

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found. The drug, Tezepelumab (also known as Tezspir and ...

To claim CE credit for this activity, please visit https://www.pharmacytimes.org/courses/emerging-care-management-strategies-for-severe-asthma-integrating-biologic ...

Monthly monoclonal antibody injection tezepelumab is so effective in patients with severe asthma, half of them are able to stop daily steroid tablets altogether, researchers have found. An ...

This resource was sponsored by Amgen. Editors from AJMC ® spoke with key opinion leaders from the Cleveland Clinic, National Jewish Health, and the University of Pittsburgh Medical Center Children’s ...

Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils], ...